• ARCA EGFP mRNA (5-moUTP) Workflow Guide

  2026-09-04

  Build a more reproducible fluorescence-based transfection control with a capped, modified, polyadenylated mRNA reporter. This guide connects practical mammalian-cell workflows with delivery-system considerations from current LNP research, helping teams distinguish transfection failure from translation, toxicity, or innate immune effects.

• ORM2–ZG16 Autophagy Axis in Pancreatic Fibrosis

  2026-09-03

  A 2026 Pancreatology study identifies ORM2 as an endogenous suppressor of chronic pancreatitis-associated fibrosis and connects its activity to ZG16-dependent regulation of autophagy in pancreatic stellate cells. The work combines pancreas-specific genetic manipulation, cellular fibrosis models, autophagy-flux assays, and protein-interaction analysis to define a mechanistic pathway with potential value for preclinical antifibrotic research.

• Aztreonam Workflows for Gram-Negative Research

  2026-09-03

  Build mechanism-aware susceptibility and resistance workflows around Aztreonam, from stock preparation and MIC testing to plasmid-context analysis. The approach also supports carefully separated exploratory assays for bone marrow progenitor cells and hepatic drug-metabolism research.

• JXY, TLR4, and Macrophages in Colitis-Associated CRC

  2026-09-02

  Liu et al. show that Jiedu Xiaozheng Yin suppresses colitis-associated colorectal cancer in mice while shifting intestinal macrophages toward an M1-like phenotype through TLR4-associated signaling. The study is notable for connecting tumor burden, macrophage function, molecular markers, and pathway-antagonism experiments in one preclinical framework.

• GPC3-HSP70 mRNA Nanovaccine in HCC

  2026-09-02

  The reference study develops an SP94-targeted mRNA nanovaccine encoding tandem GPC3^127–136 CTL epitopes fused to HSP70 and shows that it enhances antigen-specific T-cell responses against hepatocellular carcinoma. Combining this construct with anti-PD-L1 therapy produced stronger antitumor activity, highlighting how antigen design, intracellular delivery, and checkpoint blockade can be integrated in a preclinical vaccine strategy.

• Levofloxacin for Reliable Cell Assays

  2026-09-01

  Learn how Levofloxacin (SKU B1959) can support controlled antibacterial, osteoblast, and chondrocyte experiments. This scenario-driven guide covers solvent compatibility, exposure design, calcium-deposition readouts, and practical reagent selection.

• Methicillin Sodium Salt for MSSA Research

  2026-08-31

  Build reproducible MSSA susceptibility, cell-wall, and resistance assays with Methicillin sodium salt. This practical guide connects concentration-controlled workflows to the paired microbiology and susceptibility logic demonstrated in a phase 2 antibiotic study.

• Azilsartan: A Causal Lens on AT1 Signaling

  2026-08-31

  Azilsartan (TAK-536) enables selective interrogation of AT1-driven signaling across cardiovascular and neuroinflammatory models. This guide focuses on causal assay design, compartment-aware interpretation, and how the gastrodin–RAS–SIRT3 study informs experiments in reactive astrocytes and microglia.

• VE-821 ATR Kinase Inhibitor: Applied Workflows

  2026-08-30

  VE-821 is a selective ATR kinase inhibitor for connecting ATR–Chk1 checkpoint signaling with DNA damage, radiation, and chemotherapy response. This practical guide outlines assay setup, combination-testing logic, and troubleshooting while distinguishing established DDR applications from emerging antiviral questions.

• APOE, M2 Macrophages, and PTC Progression

  2026-08-29

  This study identifies APOE as a tumor-associated regulator linking papillary thyroid carcinoma cells with M2-like macrophage polarization. Its combined tissue, co-culture, signaling, and xenograft evidence suggests that APOE-driven PI3K/Akt/NF-κB activity and IL-10 production may connect tumor progression with immune remodeling.

• Selective Spectrophotometry of Phenolic β-Lactams

  2026-08-29

  Salem and Saleh developed two selective spectrophotometric assays for cefoperazone, cefadroxil, cefprozil, and amoxicillin based on oxidation with cerium(IV) or iron(III) in acidic medium. The methods produced a shared yellow chromophore and enabled quantitative analysis across pharmaceutical formulations, including mixtures containing structurally related penicillins.

• Aztreonam: From Mechanism to Translational Control

  2026-08-28

  Aztreonam is more than a synthetic monocyclic β-lactam antibiotic: it is a strategically useful perturbation tool for connecting Gram-negative bacterial phenotypes with host-cell and hepatic metabolism readouts. This thought-leadership article explains how to position Aztreonam in resistance-phenotyping workflows, interpret cefiderocol-era susceptibility data without overclaiming, and design translational studies that account for bone marrow progenitor cell inhibition, liver cytochrome P450 effects, compound handling, and assay maturity.

• Tranexamic Acid: From Mechanism to Translational Hemostasis

  2026-08-28

  Tranexamic Acid offers a mechanistically precise way to study clot stability, plasmin biology, and next-generation wound materials. This thought-leadership guide connects antifibrinolytic biochemistry with assay design, biomaterial engineering, and translational decision-making.

• Aztreonam Assay Design for Resistant Gram-Negatives

  2026-08-27

  Explore how Aztreonam can support mechanism-aware antimicrobial assays, resistance-stratified isolate testing, and translational safety studies. This guide connects monobactam biology with practical lessons from a large European cefiderocol susceptibility study.

• Neuroligin 1, D2 Neurons, and Repetitive Behavior

  2026-08-27

  This study identifies a cell-type-specific mechanism linking Neuroligin 1 loss in striatal D2 medium spiny neurons to excessive self-grooming and digging in mice. By combining behavioral analysis, neuronal activity manipulation, single-nucleus RNA sequencing, and protein validation, it implicates PKC overactivation as a contributor to D2-MSN hyperexcitability and restricted, repetitive behavior.

456 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page